Heparin-Induced Thrombocytopenia: Diagnosis and Management

Thrombosis Research

Volumn 123, Issue SUPPL. 1, 2008, Pages

  Hassell, K ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGATROBAN; FONDAPARINUX; HEPARIN; HIRULOG; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; THROMBOCYTE FACTOR 4; WARFARIN;

ARTICLE; CLINICAL FEATURE; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; LABORATORY TEST; PARTICLE GEL IMMUNOASSAY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCORING SYSTEM; SEROTONIN RELEASE ASSAY; THROMBOCYTE COUNT;

ANTICOAGULANTS; HEPARIN; HUMANS; IMMUNOGLOBULIN G; PLATELET FACTOR 4; THROMBOCYTOPENIA;

EID: 55249103594     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.08.013     Document Type: Article

References (25)

1. Warkentin T.E. Clinical presentation of heparin-induced thrombocytopenia. Semin Hematol 35 4 (1998) 9-16
2. Warkentin T.E., and Grienacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention. Chest 126 (2004) 311-337S
3. Warkentin T.E. Heparin-induced thrombocytopenia. Heme/Onc Clin NA 21 (2007) 589-607
4. Ahmed I., Majeed A., and Powell R. Heparin induced thrombocytopenia: diagnosis and management update. Postgrad Med J 83 (2007) 575
5. Selleng K., Warkentin T.E., and Greinacher A. Heparin-induced thrombocytopenia in intensive care patients. Crit Care Med 35 4 (2007) 1165-1176
6. Risch L., Bertschmann W., Heijen I., and Huber A. A differentiated approach to assess the diagnostic usefulness of a rapid particle gel immunoassay for the detection of antibodies against heparin-platelet factor 4 in cardiac surgery patients. Blood Coag Fibrinolys 14 1 (2003) 99-106
7. Alberio L., Kimmerle S., Baumann A., Teleghani B.M., Biasiutti F.D., and Lammle B. Rapid determination of anti-heparin/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia. Am J Med 114 (2003) 528-536
8. Warkentin T.E., Sheppard J.L., Horsewood P., Simpson P.J., Moore J.C., and Kelton J.G. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 96 (2000) 1703-1708
9. Giolami B., Prandoni P., Stefani P.M., Tanduo C., Sabbion P., Eichler P., et al. The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study. Blood 101 8 (2003) 2955-2959
10. Harbrecht U., Bastians B., Kredteck A., Hanfland P., Klockgether T., and Pohl C. Heparin-induced thrombocytopenia in neurologic disease treated with unfractionated heparin. Neurology 62 (2004) 657-659
11. Matsuo T., Tomaru T., Kario K., Hirokawa T., and on behalf of HIT Reaserch Group of Japan. Incidence of heparin-PF4 complex antibody formation and heparin- induced thrombocytopenia in acute coronary syndrome. Thromb Res 115 (2005) 475-481
12. Luzzatto G., Bertoli M., Cella G., Fabris F., Zaia B., and Girolami A. Platelet count, anti-heparin platelet factor 4 antibodies and tissue factor pathway inhibitor plasma antigen level in chronic dialysis. Thromb Res 89 (1998) 115-122
13. Francis J., and Drexler A. Frequency of heparin-platelet factor 4 antibodies in patients presenting to the emergency room with symptoms of thrombosis. J Thromb Haemost 1 suppl 1 (2003) P1147 (abstract)
14. Lo G.K., Sigouin C.S., and Warkentin T.E. What is the potential for over diagnosis of heparin-induced thrombocytopenia?. Amer J Hematol 82 12 (2007) 1037-1043
15. Pouplard C., Gueret P., Fouassier M., Ternisien C., Trossaert M., Regina S., et al. Prospective evaluation of the '4Ts' score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost 5 7 (2007) 1373-1379
16. Warkentin T.E., and Kelton J.G. A 14-year study of heparin-induced thrombocytopenia. Am J Med 101 5 (1996) 502-507
17. Lefkovitz J., and Topol E.J. Direct Thrombin inhibitors in cardiovascular medicine. Circulation 90 (1994) 1522-1536
18. Lewis B.E., Wallis D.E., Berkowitz S.D., and for the ARG-911 Study Investigators. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation 103 (2001) 1838-1843
19. Greinacher A., Eichler P., Lubenow N., Kwasny H., and Luz M. Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range. Blood 96 (2000) 846-851
20. Kiser T.H., and Fish D.N. Evaluation of Bivalirudin treatment for heparin-induced thrombocytopenia in critically ill patients with hepatic and/or renal dysfunction. Pharmacotherapy 26 4 (2006) 452-460
21. Dang C.H., Durkalski V.L., and Nappi J.M. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-Induced thrombocytopenia. Pharmacotherapy 26 (2006) 461-468
22. Efird L.E., and Kockler D.R. Fondaparinix for thromboembolic treatment and prophylaxis of heparin-induced thrombocytopenia. Pharmacotherapy 40 (2006) 1383-1387
23. Papadopoulos S., Flynn J.D., and Lewis D.A. Fondaparinux as a treatment option for heparin-induced thrombocytopenia. Pharmacotherapy 27 6 (2007) 921-926
24. Hassell K.L. The management of patients with HIT who require anticoagulant therapy. Chest 127 2 (2005) 1S-8S
25. Warkentin T.E., and Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Annals of Thoracic Surgery 76 2 (2003) 638-648